Effect of anti-miR-33 treatment on gene expression in mouse macrophages from atherosclerotic plaques.
Source: NCBI BioProject (ID PRJNA138685)
Source: NCBI BioProject (ID PRJNA138685)
0 0
Project name: Mus musculus
Description: Inhibition of miR-33 results in increased cholesterol efflux and HDL-cholesterol levels in mice. In this study we examined the effect of miR-33 inhibition in a mouse model of atherosclerosis and observed significant reduction in atherosclerotic plaque size. At the end of the study, gene expression in macrophages from the atherosclerotic plaques was assessed.The results demonstrated a reduction in inflammatory gene expression and increased levels of mRNAs containing miR-33 binding sites.Overall design: LDLR-/- mice on a Western diet with established atherosclerosis were switched to normal chow and treated with anti-miR-33, control anti-miR, or saline (n=4/group) for 4 weeks. Gene expression profiling was performed on macrophages in aortic plaques isolated at the end of the treatment period by laser capture microdissection.
Data type: Transcriptome or Gene expression
Sample scope: Multiisolate
Relevance: ModelOrganism
Organization: Regulus Therapeutics
Literatures
- PMID: 21646721
Release date: 2011-05-20
Last updated: 2011-04-21